The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II clinical trial of autologous CMV-specific T cells in glioblastoma (GBM) patients to reveal a lack of immune effector function.
 
Shiao-Pei S. Weathers
Research Funding - Genentech/Roche (Inst); Mundipharma (Inst)
 
Marta Penas-Prado
No Relationships to Disclose
 
Pinaki Prosad Banerjee
No Relationships to Disclose
 
Mustafa Bdiwi
No Relationships to Disclose
 
Hila Shaim
No Relationships to Disclose
 
Abdullah Alsuliman
No Relationships to Disclose
 
Mayra Shanley
No Relationships to Disclose
 
James Long
No Relationships to Disclose
 
John Frederick De Groot
Employment - ZIOPHARM Oncology (I)
Leadership - ZIOPHARM Oncology (I)
Stock and Other Ownership Interests - Gilead Sciences; ZIOPHARM Oncology (I)
Consulting or Advisory Role - Abbvie; Agios; AstraZeneca; Blue Earth Diagnostics; Boston Biomedical; CarThera; Deciphera; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; GenomiCare; GW Pharmaceuticals; Insys Therapeutics; Kadmon; Kairos Ventures; KIYATEC; Merck; Mundipharma Research; Novogen; Vascular Biogenics
Research Funding - Deciphera; EMD Serono; Lilly; Mundipharma; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - AstraZeneca - Research Support; Deciphera Pharmaceuticals - Research Support; Eli Lilly - Research Support; EMD-Serono - Research Support; Novartis - Research Support; Sanofi-Aventis - Research Support
Travel, Accommodations, Expenses - Blue Earth Diagnostics
 
Barbara Jane O'Brien
Honoraria - Seagen
 
Nazanin Majd
No Relationships to Disclose
 
Rebecca A. Harrison
No Relationships to Disclose
 
Carlos Kamiya-Matsuoka
No Relationships to Disclose
 
Gregory N. Fuller
No Relationships to Disclose
 
Linda Chi
Research Funding - GE Medical Systems (Inst)
 
Ganesh Rao
Consulting or Advisory Role - Monteris Medical
Travel, Accommodations, Expenses - Monteris Medical
 
Frederick F. Lang
Stock and Other Ownership Interests - DNAtrix
 
Elizabeth J. Shpall
Honoraria - Magenta Therapeutics; Novartis
Consulting or Advisory Role - Adaptimmune; Celgene; Magenta Therapeutics; Novartis; Velos (I); Zelluna
Travel, Accommodations, Expenses - Magenta Therapeutics; Novartis
 
Katayoun Rezvani
Honoraria - Adicet Bio; EMD Serono; Onkimmune; Onkimmune; Synthorx
Consulting or Advisory Role - Adicet Bio; Formula Pharmaceuticals; Onkimmune; ViroGen
Research Funding - Affimed Therapeutics; CytomX Therapeutics; Pharmacyclics
Patents, Royalties, Other Intellectual Property - License agreement and research agreement with Takeda to develop CB-CAR NK cells for the treatment of B-cell malignancies and other cancers, which creates an institutional conflict of interest under MD Anderson policy; Patent on generation of BKV CTLs for the treatment of HC or PML; Patent on generation of CAR NK cells
 
Amy B. Heimberger
Stock and Other Ownership Interests - Caris Life Sciences; Celldex
Consulting or Advisory Role - Caris Life Sciences
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Celldex
Travel, Accommodations, Expenses - Caris Life Sciences